{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:23:39Z","timestamp":1773833019773,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T00:00:00Z","timestamp":1631318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ymgmr.2021.100802","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T22:29:40Z","timestamp":1631744980000},"page":"100802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Severe manifestations and treatment of COVID-19 in a transplanted patient with Fabry disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Ryan","family":"Mahoney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin Ponce","family":"Zepeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Kimonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ymgmr.2021.100802_bb0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/ckj\/sfaa227","article-title":"Fabry disease and COVID-19: international expert recommendations for management based on real-world experience","volume":"13","author":"Laney","year":"2020","journal-title":"Clin. Kidney J."},{"issue":"9","key":"10.1016\/j.ymgmr.2021.100802_bb0010","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41436-019-0451-z","article-title":"Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study","volume":"21","author":"Germain","year":"2019","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgmr.2021.100802_bb0015","article-title":"Long-term follow-up of renal function in patients treated with migalastat for Fabry disease","volume":"28","author":"Bichet","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2021.100802_bb0020","unstructured":"Amicus Therapeutics Galafold\u2122 (Migalastat) Capsules, for Oral Use: US Prescribing Information 2018 https:\/\/www.fda.gov\/. Accessed 18 Oct 2018."},{"key":"10.1016\/j.ymgmr.2021.100802_bb0025","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.ymgmr.2021.100802_bb0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8.5","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.ymgmr.2021.100802_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","article-title":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Diabet. Metabol. Syndrome"},{"key":"10.1016\/j.ymgmr.2021.100802_bb0040","first-page":"41","article-title":"Prevalence of chronic kidney disease in fabry disease patients: multicenter cross sectional study in Argentina","volume":"12","author":"Jaurretche","year":"2017","journal-title":"Mol. Genet. Metabol. Rep."},{"issue":"5","key":"10.1016\/j.ymgmr.2021.100802_bb0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgmr.2021.100802_bb0050","article-title":"Collapsing Glomerulopathy in a COVID-19 Patient","volume":"Vol 98","author":"Kissling","year":"2020"},{"key":"10.1016\/j.ymgmr.2021.100802_bb0055","unstructured":"European Medicines Agency Summary on Compassionate Use of Remdesivir-gilead https:\/\/www.ema.europa.eu\/en\/documents\/other\/summary-compassionate-use-remdesivir-gilead_en.pdf 17 March 2021 date accessed."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100802_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2021.100802_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"Francesco","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"10234","key":"10.1016\/j.ymgmr.2021.100802_bb0070","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ymgmr.2021.100802_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124987","article-title":"Characterization of early disease status in treatment-naive male paediatric patients with fabry disease enrolled in a randomized clinical trial","volume":"10","author":"Wijburg","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ymgmr.2021.100802_bb0080","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","article-title":"Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)","volume":"25","author":"Fogo","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2021.100802_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2020.07.008","article-title":"Impact of COVID-19 pandemic on patients with Fabry disease: an Italian experience","volume":"131","author":"Riccio","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100802_bb0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7883\/yoken.JJID.2020.729","article-title":"When frequent (Pandemic) occurs in a non-frequent disease: COVID-19 and fabry disease: report of two cases","volume":"74","author":"G\u00f3mez-Luj\u00e1n","year":"2021","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.ymgmr.2021.100802_bb0095","article-title":"Impact of the COVID-19 pandemic on the standard of care for patients with lysosomal storage diseases: a survey of healthcare professionals in the fabry, gaucher, and hunter outcome survey registries","volume":"28","author":"Elstein","year":"2021","journal-title":"Mol. Genet. Metab. Rep."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:52:58Z","timestamp":1762001578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426921000963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":19,"alternative-id":["S2214426921000963"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100802","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe manifestations and treatment of COVID-19 in a transplanted patient with Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100802"}}